Novonesis (Novozymes) B (CHIX:NSISBC) Margin of Safety % (DCF FCF Based) : -284.71% (As of Jan. 18, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2025-01-18), Novonesis (Novozymes) B's Predictability Rank is 4.5-Stars. Novonesis (Novozymes) B's intrinsic value calculated from the Discounted FCF model is kr165.45 and current share price is kr393.90. Consequently,

Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -284.71%.

Competitive Comparison of Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based)

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) falls into.

Novonesis (Novozymes) B Margin of Safety % (DCF FCF Based) Calculation

Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)	=	(Intrinsic Value: DCF (FCF Based)	-	Current Price)	/	Intrinsic Value: DCF (FCF Based)
	=	(102.39	-	393.90)	/	102.39
	=	-284.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Novonesis (Novozymes) B Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA 0Q4U:UK NSIS B:Denmark NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines